Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,775.00
Bid: 1,774.50
Ask: 1,775.50
Change: 0.00 (0.00%)
Spread: 1.00 (0.056%)
Open: 1,775.50
High: 1,778.50
Low: 1,769.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks at one-month high on Vodafone capital return

Fri, 21st Feb 2014 11:45

- Vodafone and RBS provide a lift- Vodafone capital return lifts sentiment- IHG, Glencore Xstrata hit by downgrades- FTSE 100 at highest level in monthtechMARK 2,884.38 +0.29%FTSE 100 6,827.26 +0.21%FTSE 250 16,401.56 +0.20%UK stocks rose to levels not seen in a month on Friday as a windfall for investors at Vodafone and rumoured restructuring plans at RBS gave sentiment a lift.Markets were particularly buoyant this morning as investors speculated about which stocks could benefit from Vodafone shareholders redistributing their cash following the group's $130bn deal to sell its 45% stake in Verizon Wireless.According to analysts at Bank of America Merrill Lynch, the deal, which completes today, will be the largest capital return in corporate history and will have a drastic impact on UK trading volumes over the next few weeks.The FTSE 100 had pared gains by midday but was still trading 0.2% higher at 6,827; it has not closed above this level since January 21st. "London's main index holds above the 6,800 level for now, putting it in a position to challenge the January high of 6,867; providing the positive mood is sustained into the final week of February," said Chris Beauchamp, Market Analyst at IG. He said that the current rally "may have a little further to run".Investors largely shrugged off data this morning showing a worse-than-expected 1.5% fall in UK retail sales volumes in January. Vodafone, RBS and Glaxo provide a liftTelecoms titan Vodafone was making decent gains this morning with shareholders today set to receive a windfall from the company's sale of its holding in its US joint venture with Verizon.RBS was higher amid reports that the bank will announce plans to slash as many as 30,000 jobs, reducing its staff count to the lowest levels in more than 10 years. The speculation comes ahead of the group's 2013 results due out next week, alongside which it is expected to unveil a massive restructuring programme of its divisions.Pharmaceuticals giant GlaxoSmithKline edged higher after European regulators recommended marketing authorisation for umeclidinium, its once-daily treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.Millennium & Copthorne, the hotel firm, jumped after reporting record revenues and profits for 2013 as fourth-quarter results were boosted by the one-off sale of the bulk of the Glyndebourne development in Singapore.Sector peer InterContinental Hotels Group, however, was trading in the red after Credit Suisse lowered its recommendation from 'neutral' to 'underperform', pointing out that the shares are trading within just 4% of their all-time high at a price-to-earnings ratio of 23.Glencore Xstrata was also lower after JPMorgan Cazenove downgraded its rating on the stock from 'overweight' to 'neutral', saying that its peers have overtaken it in terms of capital returns potential.BAE Systems, which disappointed the market with its 2014 guidance yesterday, bounced slightly this morning after Societe Generale raised the stock from 'hold' to 'buy'.FTSE 100 - RisersRoyal Bank of Scotland Group (RBS) 364.10p +2.36%BAE Systems (BA.) 409.00p +2.15%ARM Holdings (ARM) 965.00p +1.90%Vodafone Group (VOD) 233.65p +1.76%Persimmon (PSN) 1,460.00p +1.60%Weir Group (WEIR) 2,355.00p +1.16%Travis Perkins (TPK) 1,984.00p +0.92%Randgold Resources Ltd. (RRS) 4,825.00p +0.81%Severn Trent (SVT) 1,812.00p +0.78%Wolseley (WOS) 3,342.00p +0.75%FTSE 100 - FallersInterContinental Hotels Group (IHG) 1,922.00p -2.68%IMI (IMI) 1,530.00p -2.24%Smiths Group (SMIN) 1,361.00p -2.09%Bunzl (BNZL) 1,469.00p -1.34%easyJet (EZJ) 1,727.00p -1.20%Prudential (PRU) 1,340.00p -1.11%International Consolidated Airlines Group SA (CDI) (IAG) 445.70p -1.07%Meggitt (MGGT) 509.00p -1.07%Glencore Xstrata (GLEN) 336.90p -1.04%ITV (ITV) 205.70p -1.01%FTSE 250 - RisersIP Group (IPO) 231.00p +7.89%Millennium & Copthorne Hotels (MLC) 598.50p +4.72%Essentra (ESNT) 882.00p +4.38%Centamin (DI) (CEY) 52.35p +3.77%Imagination Technologies Group (IMG) 187.90p +2.96%Ocado Group (OCDO) 598.00p +2.48%Big Yellow Group (BYG) 562.00p +2.46%RPC Group (RPC) 630.00p +2.36%Hunting (HTG) 838.00p +2.20%Polymetal International (POLY) 655.00p +2.18%FTSE 250 - FallersVesuvius (VSVS) 458.20p -2.86%Domino's Pizza Group (DOM) 535.00p -2.37%Evraz (EVR) 81.80p -1.56%Rank Group (RNK) 145.00p -1.56%3i Group (III) 400.50p -1.50%PZ Cussons (PZC) 358.80p -1.46%Hellermanntyton Group (HTY) 305.30p -1.45%Synthomer (SYNT) 270.20p -1.39%Cranswick (CWK) 1,288.00p -1.38%Bank of Georgia Holdings (BGEO) 2,375.00p -1.29%BC
More News
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more
17 Dec 2023 15:16

PRESS: GSK looks for deals in China as rebuilds relationship

(Alliance News) - The Financial Times on Sunday reported that GSK PLC is looking for some new deals in China.

Read more
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.